BPC-157 Dosage Chart & Schedule
A stable synthetic peptide based on a partial sequence identified in gastric juice. It is one of the most-studied research peptides for connective-tissue and gut-lining repair in animal models.
Research-community references commonly cite ~200-500 mcg/day subQ, often split AM/PM and run in 4-6 week blocks. This is a reported convention in research references, not a trial-proven human dose.
Figures describe how BPC-157 is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.
Dosage protocols
Commonly referenced research tiers. Start conservative; every compound and study context differs.
- Frequency
- Once daily
- Weekly total
- 1.75 mg
- Cycle
- 4-6 weeks, then reassess
A common entry point referenced while gauging response before splitting the daily amount.
- Frequency
- 2x daily (AM/PM)
- Weekly total
- 3.5 mg
- Cycle
- 4-6 weeks, then reassess
The most commonly referenced pattern: ~500 mcg/day split into two subQ doses.
- Frequency
- Once daily or EOD
- Weekly total
- 0.75-1.75 mg
- Cycle
- Tapering after an initial block
A lower-frequency reference used after an initial period rather than an indefinite protocol.
Preclinical evidence only
- Most BPC-157 data comes from rodent models of tendon, ligament, muscle, and gut-lining repair; no completed human clinical trial establishes a dose.
- Some research protocols reference dosing near the injury site on a theory of local action, though systemic subQ is also commonly referenced.
Regulatory status
- BPC-157 is not an approved drug; U.S. compounding of it has been restricted, and it is framed here for laboratory and research use only.
Ready to run this protocol?
Dosing is only as good as the vial. BPC-157 is third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.
Weekly schedule
A typical week on the standard protocol (2x daily (AM/PM)).
Dosing day Off
BPC-157 reconstitution
Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.
From vial to injection in 6 steps
Wipe both vial tops
Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.
Draw the water
Pull the planned amount of bacteriostatic water (2 mL) into the syringe.
Add it slowly
Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.
Let it dissolve
Wait until the solution is fully clear, then refrigerate the vial.
Draw your dose
Pull the calculated units on a U-100 insulin syringe (~5 units for 250 mcg).
Store between uses
Keep the reconstituted vial refrigerated and use within its stable window.
Handling & storage
- Reconstitute with bacteriostatic water (2 mL into a 10 mg vial = 5000 mcg/mL)
- Refrigerate reconstituted; keep the lyophilized powder cool and dark
- A 250 mcg dose draws to ~5 units on a U-100 insulin syringe
BPC-157 dosing FAQ
How much BPC-157 per week?
Research-community references commonly cite ~200-500 mcg/day, or roughly 1.4-3.5 mg/week, often split AM/PM. Human dosing is not established.
How is BPC-157 reconstituted?
Typically with bacteriostatic water. For example, 2 mL into a 10 mg vial gives 5000 mcg/mL, so a 250 mcg dose is about 5 units on a U-100 syringe.
Is BPC-157 injected near the injury?
Some research protocols reference local subQ near the affected area on a theory of local action, while systemic subQ is also common. Both are research conventions, not proven guidance.
How long is a typical BPC-157 cycle?
References commonly describe 4-6 week blocks followed by reassessment rather than continuous use.
Sources
Categories: Healing & Recovery · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.